Correlation Between Visa and Pure Biologics

Can any of the company-specific risk be diversified away by investing in both Visa and Pure Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Pure Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Pure Biologics Splka, you can compare the effects of market volatilities on Visa and Pure Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Pure Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Pure Biologics.

Diversification Opportunities for Visa and Pure Biologics

-0.59

Correlation Coefficient

Visa  Pure Biologics

Excellent diversification

The 3 months correlation between Visa and Pure is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Pure Biologics Splka in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pure Biologics Splka and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Pure Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pure Biologics Splka has no effect on the direction of Visa i.e., Visa and Pure Biologics go up and down completely randomly.

Pair Corralation between Visa and Pure Biologics

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.29 times more return on investment than Pure Biologics. However, Visa Class A is 3.5 times less risky than Pure Biologics. It trades about 0.11 of its potential returns per unit of risk. Pure Biologics Splka is currently generating about -0.14 per unit of risk. If you would invest  28,992  in Visa Class A on September 16, 2024 and sell it today you would earn a total of  2,482  from holding Visa Class A or generate 8.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.46%
Values	Daily Returns

Visa Class A  vs.  Pure Biologics Splka

Visa Class A

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pure Biologics Splka

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pure Biologics Splka has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Visa and Pure Biologics

The main advantage of trading using opposite Visa and Pure Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Pure Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pure Biologics will offset losses from the drop in Pure Biologics' long position.

The idea behind Visa Class A and Pure Biologics Splka pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.